Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
8.75
+0.63 (7.76%)
At close: Apr 28, 2026, 4:00 PM EDT
8.71
-0.04 (-0.46%)
Pre-market: Apr 29, 2026, 7:57 AM EDT
Sagimet Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -51.04 | -45.57 | -27.88 | -30.5 | -24.44 | |
| Loss (Gain) From Sale of Investments | -0.39 | -1.25 | -0.04 | -0.21 | - | |
| Stock-Based Compensation | 6.45 | 5.29 | 4.99 | 1.88 | 1.9 | |
| Other Operating Activities | 0.38 | 0.15 | 0.14 | 0.13 | 0.88 | |
| Change in Accounts Payable | 0.93 | -0.91 | 0.12 | 2.92 | 0.56 | |
| Change in Other Net Operating Assets | -1.98 | -0.14 | -1.1 | 1.3 | -0.62 | |
| Operating Cash Flow | -45.65 | -42.44 | -23.77 | -24.49 | -21.71 | |
| Investment in Securities | 4.56 | -61.68 | 12.58 | -32.01 | - | |
| Investing Cash Flow | 4.56 | -61.68 | 12.58 | -32.01 | - | |
| Issuance of Common Stock | 0.28 | 105.86 | 89.69 | 0.01 | 0.19 | |
| Other Financing Activities | - | -1.05 | -3.52 | -0.09 | -1.25 | |
| Financing Cash Flow | 0.28 | 104.82 | 86.17 | -0.07 | 9.74 | |
| Net Cash Flow | -40.82 | 0.7 | 74.98 | -56.57 | -11.97 | |
| Levered Free Cash Flow | -30.22 | -29.73 | -15.08 | -13.21 | -14.27 | |
| Unlevered Free Cash Flow | -30.22 | -29.73 | -15.08 | -13.21 | -14.27 | |
| Change in Working Capital | -1.05 | -1.05 | -0.98 | 4.21 | -0.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.